Vildagliptin Information
What is this drug used for?
Galvus is used to treat type-2 diabetes mellitus. It can be used in the following ways:
- on its own (monotherapy) in patients whose diabetes is not sufficiently controlled by diet and exercise and who cannot take metformin.
- together with metformin, a thiazolidinedione or a sulphonylurea (dual therapy) when the patient’s diabetes is insufficiently controlled by this other medicine taken alone, but it is only used in combination with a sulphonylurea in patients who cannot take metformin.
- together with a sulphonylurea and metformin (triple therapy) in patients whose diabetes is not sufficiently controlled by these medicines plus diet and exercise.
- together with insulin (with or without metformin) in patients whose diabetes is not sufficiently controlled by diet and exercise plus a stable dose of insulin.
The medicine can only be obtained with a prescription.
Medication Safety Issues
International issues:
Galvus brand name for vildagliptin [multiple international markets] may be confused with Galvumet brand name for vildagliptin and metformin [Australia, Switzerland].
Product Availability
Not available in the US
Storage and Stability
Store below 30°C (86°F). Protect from moisture.
Adverse Reactions
1% to 10%: Central nervous system: Dizziness
<1%, postmarketing, and/or case reports: Abnormal hepatic function tests, arthralgia, bullous pemphigoid, constipation, exfoliative dermatitis, headache, hepatitis (reversible), hypoglycemia, myalgia, nasopharyngitis, pancreatitis, peripheral edema, upper respiratory tract infection, urticaria –
